AER 1587052 is a spontaneous case, received on 01/Jun/2015 from a physician via company representative and 
concerns a patient of unknown demographics who developed contracted progressive multifocal 
leukoencephalopathy while being treated with rituximab (Rituxan).
No medical history, concurrent conditions,past drugs and concomitant medications were reported.
On an unknown date, the patient started therapy with rituximab (route, dose, form and frequency not reported) for 
unknown indication. On an unknown date, the patient developed contracted progressive multifocal 
leukoencephalopathy.
The outcome of contracted progressive multifocal leukoencephalopathy was not reported. It was unknown if 
therapy with rituximab was ongoing.
Print Time: 07-JUN-2016 03:01 PM If a field is blank, there is no data for that field Page 495 of 549
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
The physician did not report a causality between contracted progressive multifocal leukoencephalopathy and 
rituximab.
No further information was provided.